Osaka University · Faculty of Medicine / Graduate School of Medical Sciences · 助教

Research keywordsAdverse・Ankle・Arthritis・Bone・Cohort・Deformity・Denosumab・Discontinuation

This is a public-data preview. Personalized fit, contact angles, and saved workflows require sign-in.

• Combination of midfoot derotational osteotomy and ankle arthrodesis against neglected clubfoot: a case report2026 · Journal of Surgical Case Reports Vol. 2026 No. 1 2025年12月24日 研究論文（学術雑誌）
• Author response to letter to the editor, “PINP-guided osteoporosis treatment selection: methodological considerations for cut-off, endpoint, fracture confounding and teriparatide heterogeneity”2026 · Bone 2026年2月 研究論文（学術雑誌）
• Baseline serum PINP is associated with early lumbar spine bone mineral density gains during twice-weekly teriparatide treatment: the OASIS cohort study2026 · Osteoporosis International 2026年4月6日 研究論文（学術雑誌）
• Author response to letter to the editor, “Comment on “Impact of baseline PINP on the BMD increase with romosozumab, teriparatide, and denosumab in treatment-naïve primary osteoporosis: A retrospective cohort study””2026 · Bone 2026年2月 研究論文（学術雑誌）

• 骨粗鬆症の病態における新規内在性NF-κB阻害因子MTI-Ⅱの機能解明
• 内在性nuclear factor kappa B阻害因子MTI-Ⅱの骨粗鬆症病態における機能の解明
• 抗nuclear factor kappa B（NF-κB）作用の低分子ペプチドを用いた新規骨粗鬆症治療の探求
• 新規Nuclear factor kappa B（NF-κB）阻害ペプチドによる新規骨粗鬆症治療法の開発

• Official profile